NCT00432679View on ClinicalTrials.gov

A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

May 24, 2006

Primary Completion Date

March 28, 2007

Study Completion Date

March 28, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone (BRL49653C)

study drug

Trial Locations (4)

212-0024

GSK Investigational Site, Kanagawa

862-0976

GSK Investigational Site, Kumamoto

870-0039

GSK Investigational Site, Ōita

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY